We are live on ! Find out more

459 hedge funds and large institutions have $5.6B invested in Chemours in 2017 Q1 according to their latest regulatory filings, with 92 funds opening new positions, 108 increasing their positions, 158 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more call options, than puts

Call options by funds: $113M | Put options by funds: $46.6M

124% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 41

100% more funds holding in top 10

Funds holding in top 10: 612 (+6)

79% more capital invested

Capital invested by funds: $3.13B → $5.6B (+$2.47B)

10% more funds holding

Funds holding: 417459 (+42)

0.99% more ownership

Funds ownership: 78.04%79.03% (+0.99%)

32% less repeat investments, than reductions

Existing positions increased: 108 | Existing positions reduced: 158

Holders
459
Holders Change
+42
Holders Change %
+10.07%
% of All Funds
11.38%
Holding in Top 10
12
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+100%
% of All Funds
0.3%
New
92
Increased
108
Reduced
158
Closed
41
Calls
$113M
Puts
$46.6M
Net Calls
+$66.4M
Net Calls Change
+$40.6M

CC Hedge Fund Activity: Q1 2017 in Review

459 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2017, worth a combined $5.6B — up 79% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new CC positions and 41 closed out — a net gain of 51 holders — while 108 added to existing stakes and 158 trimmed.

The largest buyer was BlackRock, adding an estimated $575M. The largest seller was Greenlight Capital, cutting an estimated $119M.

  • 459 institutional investors held Chemours (CC) as of Q1 2017, up from 417 in Q4 2016.
  • Funds reported $5.6B of Chemours stock for Q1 2017, up 79% quarter-over-quarter.
  • 92 funds opened new Chemours positions in Q1 2017 and 41 closed out, a net change of +51 holders.
  • The largest Chemours buyer in Q1 2017 was BlackRock, an estimated $575M added.
  • The largest Chemours seller in Q1 2017 was Greenlight Capital, an estimated $119M sold.

Based on aggregated 13F filings for Q1 2017.